Peripheral neuropathy in rats exposed to dichloroacetate

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 9, 2009, Pages 985-993

  Calcutt, Nigel A ^a   Lopez, Veronica L ^a   Bautista, Arjel D ^a   Mizisin, Leah M ^a   Torres, Brenda R ^a   Shroads, Albert L ^b   Mizisin, Andrew P ^a   Stacpoole, Peter W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Axons; Dichloroacetate; Mitochondria; Neurotoxicity; Peripheral neuropathy

Indexed keywords

DICHLOROACETIC ACID;

AGE; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; ELECTROMYOGRAPHY; FEMALE; FOOT; HYPESTHESIA; INNERVATION; NERVE CONDUCTION; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; RAT; SKIN; SPRAGUE DAWLEY RAT;

AGE FACTORS; ANIMALS; DICHLOROACETATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMYOGRAPHY; FEMALE; FOOT; HYPESTHESIA; NEURAL CONDUCTION; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SKIN;

EID: 70349563151     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181b40217     Document Type: Article

References (36)

1. Stacpoole PW, Kurtz TL, Han Z, et al. Role of dichloroacetate in the treatment of genetic mitochondrial diseases. Adv Drug Deliv Rev 2008; 60:1478-87
2. Stacpoole PW, Moore GW, Kornhauser DM. Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med 1978;298:526-30
3. Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med 1992;327: 1564-69
4. Berendzen K, Theriaque DW, Shuster J, et al. Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency. Mitochondrion 2006;6:126-35 (Pubitemid 43872023)
5. Bonnet S, Archer SL, Allalunis-Turner J, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007;11:37-51 (Pubitemid 46054520)
6. Pearson H. Cancer patients opt for unapproved drug. Nature 2007;446: 474-75 (Pubitemid 46514699)
7. Spruijt L, Naviaux RK, McGowan KA, et al. Nerve conduction changes in patients with mitochondrial diseases treated with dichloroacetate. Muscle Nerve 2001;24:916-24 (Pubitemid 32549975)
8. Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial. Neurology 2006;66:324-30 (Pubitemid 43739931)
9. Stacpoole PW, Gilbert LR, Neiberger RE, et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics 2008;121:1223-28
10. DeAngelo AB, Daniel FB, Most BM, et al. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 1996;114: 207-21 (Pubitemid 26421934)
11. Yount EA, Felten SY, O'Connor BL, et al. Comparison of the metabolic and toxic effects of 2-chloropropionate and dichloroacetate. J Pharmacol Exp Ther 1982;222:501-8 (Pubitemid 12047288)
12. Katz R, Tai CN, Diener RM, et al. Dichloroacetate, sodium: 3-Month oral toxicity studies in rats and dogs. Toxicol Appl Pharmacol 1981;57: 273-87 (Pubitemid 11155165)
13. Stacpoole PW, Moore GW, Kornhauser DM. Toxicity of chronic dichloroacetate. N Engl J Med 1979;300:372 (Pubitemid 9114903)
14. Cicmanec JL, Condie LW, Olson GR, et al. 90-Day toxicity study of dichloroacetate in dogs. Fundam Appl Toxicol 1991;17:376-89
15. Yeomans DC, Proudfit HK. Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: Electrophysiological evidence. Pain 1996;68:141-50 (Pubitemid 126407766)
16. Calcutt NA. Modeling diabetic sensory neuropathy in rats. Methods Mol Med 2004;99:55-65
17. Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63 (Pubitemid 24238751)
18. Calcutt NA, Campana WM, Eskeland NL, et al. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats. J Neuropathol Exp Neurol 1999;58:628-36 (Pubitemid 29264942)
19. Beiswenger KK, Calcutt NA, Mizisin AP. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett 2008;442:267-72
20. Beiswenger KK, Calcutt NA, Mizisin AP. Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem 2008;110:351-62
21. Cunha JM, Jolivalt CG, Ramos KM, et al. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: Effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism 2008; 57:873-81 (Pubitemid 351814678)
22. Fruhwirth GO, Loidl A, Hermetter A. Oxidized phospholipids: From molecular properties to disease. Biochim Biophys Acta 2007;1772: 718-36 (Pubitemid 46891216)
23. Fitzmaurice PS, Tong J, Yazdanpanah M, et al. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. J Pharmacol Exp Ther 2006; 319:703-9
24. Luo XP, Yazdanpanah M, Bhooi N, et al. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal Biochem 1995;228:294-8
25. Freireich EJ, Gehan EA, Rall DP, et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep 1966;50:219-44
26. Stacpoole PW, Harwood HJ, Cameron DF, et al. Chronic toxicity of dichloroacetate: Possible relation to thiamine deficiency in rats. Fundam Appl Toxicol 1990;14:327-37 (Pubitemid 20104235)
27. Sunderland S, Roche AF. Axon-myelin relationships in peripheral nerve fibres. Acta Anat 1958;33:1-37
28. Jakobsen J. Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves. Diabetologia 1976;12:539-46
29. Felitsyn N, McLeod C, Shroads AL, et al. The heme precursor delta-aminolevulinate blocks peripheral myelin formation. J Neurochem 2008;106:2068-79
30. Felitsyn N, Stacpoole PW, Notterpek L. Dichloroacetate causes reversible demyelination in vitro: Potential mechanism for its neuropathic effect. J Neurochem 2007;100:429-36 (Pubitemid 46011003)
31. Calcutt NA, Muir D, Powell HC, et al. Reduced ciliary neuronotrophic factorYlike activity in nerves from diabetic or galactose-fed rats. Brain Res 1992;575:320-24
32. Mizisin AP, Calcutt NA, DiStefano PS, et al. Aldose reductase inhibition increases CNTF-like bioactivity and protein in sciatic nerves from galactose-fed and normal rats. Diabetes 1997;46:647-52 (Pubitemid 27143382)
33. Mizisin AP, Vu Y, Shuff M, et al. Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes 2004;53:1807-12 (Pubitemid 38857039)
34. Shroads AL, Guo X, Dixit V, et al. Age-dependent kinetics and metabolism of dichloroacetate: Possible relevance to toxicity. J Pharmacol Exp Ther 2008;324:1163-71 (Pubitemid 351397850)
35. Stacpoole PW, Kerr DS, Barnes C, et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 2006;117:1519-31 (Pubitemid 46071378)
36. Subba Rao K. Mechanisms of disease: DNA repair defects and neurological disease. Nat Clin Pract Neurol 2007;3:162-72